Építés alatt – nem éles oldal
Belépés

What researchers published on Hasnyálmirigyrák

55 847 papers, newest first.

Showing 100 of 55 847

  • Tumor location in the pancreatic body/tail as an independent risk factor for early recurrence after curative resection of pancreatic ductal adenocarcinoma: a single-center retrospective study.Frontiers in oncology
  • Prospective Evidence of Concomitant Pancreatic Ductal Adenocarcinoma Risk Among Patients With Branch-duct Intraductal Papillary Mucinous Neoplasms Without Worrisome Features/High-risk Stigmata at Baseline.Annals of surgery
  • A biomimetic desmoplastic pancreatic cancer organoid model reveals macrophage contributions to stiffness-associated chemoresistance.Matrix biology plus
  • Malignant melanoma of unknown primary mimicking pancreatic cancer diagnosed by EUS-guided fine-needle biopsy: NRAS mutation and a rare KIT exon 17 variant.Endoscopic ultrasound
  • ÁttekintésPatient-Derived Organoids in Pancreatic Cancer Pharmacology: From Pharmacotyping Methodology to the AVATAR Phase III Trial and the Pharmacological Frontier.Drug design, development and therapy
  • Targeting SUMOylation in Combination with Agonistic Anti-CD40 Therapy Activates Anti- Tumor Immunity to Control Pancreatic Cancer.Molecular cancer therapeutics
  • ÁttekintésEarly detection and interception in hepato-pancreatic-biliary cancers: endoscopic imaging, liquid biopsy, and emerging molecular biomarkers.Frontiers in oncology
  • ÁttekintésPreoperative Biliary Drainage for Pancreatobiliary Tumor.Journal of Korean medical science
  • EsetismertetésPancreatic ductal adenocarcinoma with atypical biliary obstruction secondary to tension pneumobilia: a case report.Journal of medical case reports
  • ÁttekintésmiR-221 and miR-222 in pancreatic ductal adenocarcinoma: mechanistic evidence, extracellular vesicle communication, biomarker candidates, and therapeutic prospects.Cancer treatment and research communications
  • Reply to the Letter to the Editor: Evaluation of P-POSSUM Risk Scoring System in Prediction of Morbidity and Mortality after Pancreaticoduodenectomy.Chirurgia (Bucharest, Romania : 1990)
  • ASO Visual Abstract: Prognostic Impact of the Combined Use of CA19-9 and DUPAN-2 in Initially Unresectable Locally Advanced Pancreatic Adenocarcinoma.Annals of surgical oncology
  • High-Sensitivity Detection of Early Pancreatic Cancer Using a Structured Scoring System Among Clinically Selected Outpatients: A Nationwide Prospective Study.United European gastroenterology journal
  • Letter to the Editor: Evaluation of P-POSSUM Risk Scoring System in Prediction of Morbidity and Mortality after Pancreaticoduodenectomy.Chirurgia (Bucharest, Romania : 1990)
  • Inkjet-printed single cell-derived pancreatic cancer organoid for intratumoral heterogeneity quantification.Biofabrication
  • Mesentericoportal Venous Shunting in Surgery for Locally Advanced Pancreatic Tumors: Results of a Standardized Approach for Oncovascular Pancreatic Surgery.Annals of surgical oncology
  • An asymmetric split-costimulatory MSLN.BBz/NKG2D.28 dual CAR-T design enhances activity against antigenically heterogeneous pancreatic cancer.Molecular therapy. Oncology
  • OSBPL3 promotes pancreatic ductal adenocarcinoma progression through lipid metabolism reprogramming and is targeted by lupenone.European journal of pharmacology
  • ÁttekintésComputational and experimental strategies for functional validation of non-coding variants in pancreatic cancer.Functional & integrative genomics
  • ASO Visual Abstract: CARG Score Predicts Perioperative Chemotherapy Completion in Pancreatic Cancer: Association of Completion with Overall Survival.Annals of surgical oncology
  • Integrating metabolism and immunity: targeting lactate-mediated mechanisms in PDAC.Cancer & metabolism
  • AKR1B1-dependent ferroptosis defense contributes to KRASG12C inhibitor resistance in pancreatic ductal adenocarcinoma.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
  • Beyond physician perspectives: advancing simultaneous care in pancreatic adenocarcinoma through multidisciplinary and implementation science approaches.The journal of nutrition, health & aging
  • ÁttekintésHepatocellular Carcinoma and Pancreaticobiliary Tumors.Magnetic resonance imaging clinics of North America
  • Phase I dose-escalation study of stereotactic body radiotherapy with elective nodal irradiation for borderline resectable and unresectable locally advanced pancreatic cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • ACSL5 suppresses pancreatic cancer progression and gemcitabine resistance by regulating n-6 docosapentaenoic acid metabolism.Cell death & disease
  • ÁttekintésTumo​r-associated macrophages in ovarian, prostate, thyroid and pancreatic neuroendocrine tumors: molecular crosstalk and therapeutic perspectives.Molecular biology reports
  • ÁttekintésUnifying functional experimental systems with clinical predictive technologies for personalized care in PDAC.Molecular cancer
  • Áttekintés[Research progress of irreversible electroporation for pancreatic cancer].Zhonghua nei ke za zhi
  • Bioabsorbable spacer-assisted high-dose proton beam therapy for unresectable locally advanced pancreatic cancer of the body or tail: a feasibility and safety study.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • Schisandrin B Suppresses Pancreatic Ductal Adenocarcinoma Through EGFR/AKT/mTOR Signaling and Mitochondrial Dysfunction.International journal of molecular sciences
  • ÁttekintésSynergizing Against RAS: The Evolving Landscape of Targeted Combinations in Pancreatic Cancer.Cancers
  • Activity of Fluoro-Substituted 3,5-Di[(E)-Benzylidene]piperidin-4-Ones with N-Arylsulfonyl Appendages Against KRAS-Mutant Pancreatic Ductal Adenocarcinoma Cells.International journal of molecular sciences
  • ÁttekintésCirculating Tumor DNA Across the Patient Journey in Pancreatic Cancer: From Molecular Profiling to Dynamic Disease Monitoring.Cancers
  • ÁttekintésTreatment Strategies and Future Directions for Locally Advanced Pancreatic Cancer.Cancers
  • Yellow, Red, and Black Lepidium meyenii Preparations Differentially Modulate Doxorubicin Response and Lipid Metabolism-Related Changes in Pancreatic Cancer Cells.Molecules (Basel, Switzerland)
  • Long-Term Outcomes of Anatomical and Biological Borderline Resectable Pancreatic Ductal Adenocarcinoma After Gemcitabine/S-1-Based Neoadjuvant Chemoradiotherapy.Cancers
  • ÁttekintésThe Association Between Asthma and Pancreatic Cancer: A Systematic Review.Cancers
  • OTI1H1-Defined MAGEA3-Directed Immunoreactivity and Survival in Pancreatic Ductal Adenocarcinoma: A Single-Center Study.Journal of clinical medicine
  • Cellularity Improvement of EUS-FNB Specimens for Pancreatic Adenocarcinoma Using a Cell-Capturing Scaffold.Journal of clinical medicine
  • Tissue miR-143 and miR-29b Expression as Prognostic Biomarkers in Patients with Resected Pancreatic Ductal Adenocarcinoma Receiving Adjuvant Chemotherapy.Diagnostics (Basel, Switzerland)
  • The Cholecystokinin-B Receptor as a Candidate Diagnostic Biomarker and Translational Target for Precision Oncology in Pancreatic Cancer.Cancers
  • Kynureninase Is a Prognostic Biomarker of Poor Survival and Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma.International journal of molecular sciences
  • Targeting ELF3 with Biomimetic Nanotherapy Sensitizes PDAC to Gemcitabine via GSDME-mediated Pyroptosis.Pharmacological research
  • LncRNA signatures associated with exhausted CD8⁺T cells for assessing the immune microenvironment and drug sensitivity in pancreatic adenocarcinoma.Neoplasia (New York, N.Y.)
  • Explainable artificial intelligence identifies circulating microRNA candidate biomarkers for liquid biopsy-based pancreatic cancer detection.Frontiers in artificial intelligence
  • Simple Algorithm for Blood Morphology Analysis (SAMBA): An Artificial Intelligence-Assisted Approach to Identify Peripheral Blood Phenotypes in a Cohort of Patients with Pancreatic Ductal Adenocarcinoma (PDAC).Cancers
  • ÁttekintésFood Environment, Food Access, and Disparities in Pancreatic Cancer Outcomes: A Narrative Review of Evidence Gaps and Future Directions.Nutrients
  • ÁttekintésPeriodontitis and pancreatic cancer: the oral-gut microbial axis, pathogenic mechanisms, and potential therapeutic implications.Journal of oral microbiology
  • ÁttekintésChanging Course: Semaphorins and Plexins as Novel Therapeutic Opportunities and Key Regulators of Pancreatic Cancer Microenvironment.International journal of molecular sciences
  • Hydrophobic ion pairing enabled self-nanoemulsifying niclosamide for pancreatic cancer: improved drug loading and kinetic solubility.International journal of pharmaceutics
  • Corrigendum to: Targeting Glutamine Metabolic Reprogramming in Pancreatic Cancer: Current Insights and Future Directions.Current cancer drug targets
  • Depletion of Endogenous IL-18 Suppresses Pancreatic Cancer Progression, Reprograms the Tumor Microenvironment, and Enhances KRAS Inhibitor Efficacy.Gastroenterology
  • PRMT1 blockade reverts resistance to KRAS (G12C) inhibition through modulating ferroptosis signalling.International journal of oncology
  • A window-of-opportunity trial testing single-dose neoadjuvant hepatic arterial floxuridine and oxaliplatin for patients with localized pancreatic cancer: analysis of safety, feasibility, and interim oncologic outcomes.HPB : the official journal of the International Hepato Pancreato Biliary Association
  • Radical antegrade modular pancreatosplenectomy versus conventional distal pancreatosplenectomy for left-sided pancreatic ductal adenocarcinoma: a multicenter propensity score-matched analysis.Annals of surgical treatment and research
  • ÁttekintésImmune cell metabolic reprogramming in pancreatic cancer: roles in tumor progression and therapeutic strategies.Frontiers in immunology
  • EsetismertetésRecurrent Multi-territory Thromboembolism As the Initial Presentation of Pancreatic Adenocarcinoma and Suspected Nonbacterial Thrombotic Endocarditis.Cureus
  • Clinical Impact in Pancreatic Cancer Trials: Time to Raise the Bar.Annals of surgery
  • Impact of Clonal Hematopoiesis on Outcomes in Metastatic Pancreatic Ductal Adenocarcinoma: Analysis From the PASS-01 Trial.JCO precision oncology
  • Randomizált vizsgálatTumor Treating Fields and Quality of Life Among Patients With Locally Advanced Pancreatic Adenocarcinoma: A Secondary Analysis of a Randomized Clinical Trial.JAMA network open
  • Pulmonary metastasectomy for isolated pulmonary metastases from pancreatic cancer: Patient selection and outcomes in a single-center retrospective cohort.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • Identification and characterization of a novel fungal pyranose 2-oxidase from the Punctularia strigosozonata with potent cytotoxicity against pancreatic carcinoma cell lines.Frontiers in molecular biosciences
  • A Spatial Multi-omics Atlas of Intra- and Extrapancreatic Perineural Invasion Reveals Basal-like Neurotropism and Stromal Remodeling in Pancreatic Cancer.Cancer letters
  • FGFBP2 p.T186S mutation in tumor associated fibroblasts supports progression of pancreatic cancer through autocrine and paracrine mechanisms.Journal of translational medicine
  • ELF3 (E74 like ETS transcription factor 3) promotes tumor growth and autophagy in pancreatic cancer.Journal of experimental & clinical cancer research : CR
  • Re: Prognostic Utility of the Cachexia Index in Resectable and Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Chemotherapy.Pancreas
  • Bone metastases identify a high-risk subgroup in metastatic neuroendocrine tumors with particular relevance in NETs of unknown primary.Frontiers in endocrinology
  • Gut microbiota-driven hippuric acid hydrolysis promotes pancreatic tumorigenesis by suppressing NK cell activity.Journal of translational medicine
  • Mucin-1 (MUC1) up-regulates autophagy-related 12 (ATG12) mRNA and protein levels in pancreatic cancer cell lines.Biochemical and biophysical research communications
  • Multi-targeted Mechanisms of Erianin against Pancreatic Ductal Adenocarcinoma: Integrative Network Pharmacology, Bioinformatics, and Experimental Validation.Current drug targets
  • Anlotinib Plus S-1 in Advanced Pancreatic Cancer: Efficacy, Safety, and Relevance to Chronic Cancer Care.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • Knockdown of HMGB1 Suppresses Hypoxia-Induced Mitochondrial Biogenesis in Pancreatic Cancer Cells [Retraction].OncoTargets and therapy
  • Correction: CHST12: a potential prognostic biomarker related to the immunotherapy response in pancreatic adenocarcinoma.Frontiers in endocrinology
  • Megfigyeléses vizsgálatHistopathological findings associated with prognosis in resected ductal adenocarcinoma of the pancreas.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery
  • PDAC: Efficient coreset selection for continual learning via probability density awareness.Neural networks : the official journal of the International Neural Network Society
  • ÁttekintésRecent Advancements in Diagnosis and Targeted Therapy of Pancreatic Cancer.Anti-cancer agents in medicinal chemistry
  • MetaanalízisPrognostic factors for resectable pancreatic adenocarcinoma: a systematic review and meta-analysis.BMC surgery
  • Awareness of the signs and symptoms of pancreatic cancer: a cross-sectional study from a developing country setting.Future science OA
  • Hepatocyte Serine Fuels Pancreatic Cancer Liver Metastasis.Cancer discovery
  • A TROP2-targeting aptamer enables selective drug delivery and potent antitumor activity in pancreatic cancer.Science advances
  • Natural history and pancreatic cancer risk in PRSS1-associated hereditary pancreatitis: a nationwide cohort.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • ÁttekintésTumor microenvironment-driven therapeutic resistance in pancreatic ductal adenocarcinoma.Cancer drug resistance (Alhambra, Calif.)
  • Beyond physician perspectives: advancing simultaneous care in pancreatic adenocarcinoma through multidisciplinary and implementation science approaches.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • EsetismertetésManagement of an incidentally discovered pancreatic neoplasm mimicking an ovarian neoplasm during pregnancy: A case report.Medicine
  • MetaanalízisGeriatric nutritional risk index as a potential prognostic indicator in pancreatic cancer: evidence from a systematic review and meta-analysis.Aging clinical and experimental research
  • Randomized multicentre Phase 2 clinical trial of non-viral gene therapy for pancreatic cancer: clinical and molecular findings.Cancer drug resistance (Alhambra, Calif.)
  • Exploratory mendelian randomization of circulating metabolites and multi-omics characterization of ERCC1 in pancreatic cancer.Functional & integrative genomics
  • A New Optimal Cut-Points Selection Method for Diseases With Multiple Ordinal Stages and Its Confidence Interval Estimation.Pharmaceutical statistics
  • MetaanalízisPostoperative Tumor-Informed Circulating Tumor DNA Status for Molecular Residual Disease Detection After Curative-Intent Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.Journal of gastrointestinal cancer
  • Vaccinia-related kinase 2 confers pancreatic cancer with gemcitabine resistance through TPI1-driven aerobic glycolysis.Cell death discovery
  • FOXO3a suppression predicts poor prognosis and facilitates cell migration and invasion through the WNT/β-catenin pathway in pancreatic ductal adenocarcinoma.Translational oncology
  • Foundation-model imaging biomarkers for pancreatic cancer: cross-species discovery of conserved tumour biology in mouse MRI and human CT.EBioMedicine
  • Social Deprivation, not Rurality, is Associated with Receipt of Guideline-concordant Care for Pancreatic Cancer in North Carolina, USA.Annals of surgical oncology
  • Albumin-bound paclitaxel-induced stromal reprogramming drives resistance to neoadjuvant chemotherapy in patients with pancreatic cancer.Science translational medicine
  • Three cases of pancreatectomy for locally advanced pancreatic cancer with arterial aberrations: case series and literature review.International journal of surgery case reports
  • Long Noncoding RNA LINC00941 Links Oncogenic KRAS Signaling to Aggressiveness, DNA Repair, and Chemoresistance in Pancreatic Cancer.IUBMB life
  • ÁttekintésTargeting lipid metabolism to overcome immunosuppression and enhance immunotherapy or chemotherapy sensitivity in pancreatic cancer: from immunosuppressive mechanisms to therapeutic opportunities.Molecular biology reports
  • Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound-guided sampling of pancreatic ductal adenocarcinoma.Cancer cytopathology
  • ECHS1 K115 succinylation inhibits fatty acid β-oxidation in pancreatic ductal adenocarcinoma.Cell reports